Today, GE HealthCare and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of ...

A new scientific statement from the American Heart Association highlights new clinical data related to diagnosis, risk classification and treatment, emphasizing the need for tailored management strate ...

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...

It aids in medical diagnosis and imaging by detecting diseases in early stages through image analysis and predicting risks based on electronic health records. Active A.I. companies active ...

Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock.

Digital Pathology Market. In 2023, the digital pathology market is expected to be valued at USD 7,035.8 million USD. By 2033, the market is anticipated to reach USD 24,961.8 milli ...

Q3 2024 Earnings Call Transcript November 6, 2024 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.79, ...

From remote monitoring of maternity patients to digital pathology, ASX companies are tackling healthcare labour shortages ...

A diagnostic medical sonographer could be answering ... turn to for information about their condition. With advances in imaging technology, many medical facilities use it in place of costly ...

Neuraceq ® is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive ...